| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 70.44B | 70.01B | 67.73B | 56.79B | 49.98B | 44.06B |
| Gross Profit | 18.51B | 17.98B | 16.35B | 13.40B | 11.87B | 11.07B |
| EBITDA | 6.06B | 5.81B | 7.30B | 5.50B | 4.69B | 5.18B |
| Net Income | 3.32B | 2.81B | 3.60B | 2.48B | 1.52B | 2.38B |
Balance Sheet | ||||||
| Total Assets | 69.41B | 70.85B | 69.39B | 60.16B | 54.30B | 53.24B |
| Cash, Cash Equivalents and Short-Term Investments | 21.20B | 21.90B | 18.94B | 18.02B | 14.77B | 14.25B |
| Total Debt | 5.48B | 5.31B | 5.75B | 5.53B | 5.15B | 4.94B |
| Total Liabilities | 21.05B | 22.37B | 25.07B | 21.12B | 18.77B | 18.56B |
| Stockholders Equity | 45.44B | 45.51B | 41.56B | 36.65B | 33.39B | 31.97B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.92B | 3.95B | 3.06B | 988.00M | 3.35B |
| Operating Cash Flow | 0.00 | 5.71B | 5.33B | 4.17B | 2.10B | 4.32B |
| Investing Cash Flow | 0.00 | -1.38B | -3.90B | -2.51B | -1.46B | -1.81B |
| Financing Cash Flow | 0.00 | -1.45B | -1.70B | -482.00M | -1.69B | -574.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥29.36B | 8.70 | ― | 2.30% | -0.94% | 51.59% | |
77 Outperform | ¥17.31B | 8.16 | ― | 4.07% | -1.64% | 6.18% | |
75 Outperform | ¥32.17B | 8.99 | ― | 4.67% | -3.82% | 18.03% | |
66 Neutral | ¥25.86B | 15.73 | ― | 3.45% | 0.49% | 29.48% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | ¥20.98B | 6.60 | ― | 3.89% | 10.01% | 47.35% | |
59 Neutral | ¥7.61B | 20.03 | ― | 2.88% | 1.08% | 82.69% |